The endothelium-derived hyperpolarizing factor (EDHF) to maintain vascular tone actually exists

维持血管张力的内皮源性超极化因子(EDHF)确实存在

基本信息

  • 批准号:
    16590210
  • 负责人:
  • 金额:
    $ 1.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Vascular endothelial cells synthesize and release various vasorelaxing factors, including nitric oxide (NO) and an endothelium-derived hyperpolarizing factor (EDHF), which regulate the tonus of underlying smooth muscle cells. It is now widely accepted that EDHF, together with NO, is associated with regulation of the vascular caliber in small arteries. However, there is not yet universal agreement on the nature of EDHF, the cellular processes that mediate EDHF-mediated hyperpolarization, or its physiological and pathophysiological significance. Thus, as a first step, the present study attempted to establish a real-time analysis for measurement of EDHF-mediated hyperpolarization and relaxation in vascular smooth muscle cells. Changes of the smooth muscle cell membrane potential and contraction-relaxation response were coincidentally determined using confocal fluorescence microscopy. The findings were used to examine the characteristics of the EDHF-mediated response in mesenteric arteries of SHR/NDmcr-cp (SHR-cp) rats, a rat model of metabolic syndrome.To measure the smooth muscle cell membrane potential induced by acetylcholine in rat mesenteric arteries, they were visualized using a membrane potential-sensitive fluorescence dye, DiBAC_4. The distance between wires inserted into a vessel was determined using the NIH image as a vasorelaxation response. We found that acetylcholine induced sustained and stable hyperpolarization in the presence of nitro-L-arginine methyl ester, an inhibitor of NO synthase. Furthermore, EDHF-mediated hyperpolarization and vasorelaxation in mesenteric arteries of SHR-cp rats were reduced compared with those of Wistar-Kyoto rats. In contrast, NO-mediated relaxation was increased in SHR-cp rats. These findings suggest that impairment of the EDHF-mediated response occurs in metabolic syndrome, and that the possibility of a back-up mechanism between NO and EDHF has important pathophysiological implications.
血管内皮细胞合成和释放各种血管松弛因子,包括一氧化氮(NO)和内皮衍生超极化因子(EDHF),它们调节底层平滑肌细胞的张力。现在人们普遍认为,EDHF和NO一起与小动脉的血管管径调节有关。然而,对于EDHF的性质、介导EDHF介导的超极化的细胞过程或其生理和病理生理学意义,目前还没有普遍的共识。因此,作为第一步,本研究试图建立一种实时分析方法来测量EDHF介导的血管平滑肌细胞的超极化和松弛。用共聚焦荧光显微镜同时测定平滑肌细胞膜电位和收缩-松弛反应的变化。为研究代谢综合征大鼠模型SHR/NDmcr-cp(SHR-cp)肠系膜动脉EDHF介导的反应特征,采用膜电位敏感型荧光染料DiBAC_4对乙酰胆碱诱导的大鼠肠系膜动脉平滑肌细胞膜电位进行了观察,并用NIH图像确定了插入血管的导线之间的距离作为血管松弛反应。我们发现,在一氧化氮合酶抑制剂--硝基-L-精氨酸甲酯存在下,乙酰胆碱可诱发持续稳定的超极化。此外,SHR-cp大鼠肠系膜动脉EDHF介导的超极化和血管舒张性较Wistar-京都大鼠明显减弱。相反,SHR-cp大鼠的NO介导的松弛作用增强。这些发现提示代谢综合征患者存在EDHF介导的反应障碍,NO和EDHF之间可能存在一种后备机制具有重要的病理生理学意义。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome
  • DOI:
    10.1016/j.lfs.2005.06.029
  • 发表时间:
    2006-02-09
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Kagota, S;Yamaguchi, Y;Shinozuka, K
  • 通讯作者:
    Shinozuka, K
Chronic nitric oxide exposure alters the balance between endothelium-derived relaxing factors released from rat renal arteries : prevention by treatment with NOX-100, a NO scavenger.
慢性一氧化氮暴露改变了大鼠肾动脉释放的内皮衍生舒张因子之间的平衡:通过使用 NOX-100(一种 NO 清除剂)治疗进行预防。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Gokan N;Kikuchi H;Nakamura K;Oshima Y;Hosaka K;Kubohara Y.;Kagota S. et al.
  • 通讯作者:
    Kagota S. et al.
Characteristics of vasorelaxation responses in a rat model of metabolic syndrome.
代谢综合征大鼠模型血管舒张反应的特征。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    C.Ohta;K.Haraguchi;Y.Kato;N.Koga;Kagota S. et al.
  • 通讯作者:
    Kagota S. et al.
Sustaining Excessive Nitric Oxide Upregulates Protein Expression of Nitric Oxide Synthase via Soluble Guanylyl Cyclase: An In Vivo Study in Rats
  • DOI:
    10.1097/00005344-200407000-00006
  • 发表时间:
    2004-07
  • 期刊:
  • 影响因子:
    3
  • 作者:
    S. Kagota;Y. Yamaguchi;Kazuki Nakamura;K. Shinozuka;M. Kunitomo
  • 通讯作者:
    S. Kagota;Y. Yamaguchi;Kazuki Nakamura;K. Shinozuka;M. Kunitomo
Disurbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome
代谢综合征模型 SHR/NDmcr-cp 大鼠中一氧化氮/环磷酸鸟苷系统的紊乱
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kagota S;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAGOTA Satomi其他文献

KAGOTA Satomi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAGOTA Satomi', 18)}}的其他基金

Dysfunction of perivascular adipose tissue exacerbates metabolic syndrome
血管周围脂肪组织功能障碍加剧代谢综合征
  • 批准号:
    16K08563
  • 财政年份:
    2016
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of protease-activated receptor 2 in metabolic syndrome
蛋白酶激活受体2在代谢综合征中的作用
  • 批准号:
    23590315
  • 财政年份:
    2011
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
  • 批准号:
    EP/X027198/2
  • 财政年份:
    2024
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Fellowship
Combining Chemical Reaction with Single Cell Mass Spectrometry for Real-time Quantification of Nitric Oxide (NO) Inside Live Single Cells
将化学反应与单细胞质谱法相结合,实时定量活单细胞内的一氧化氮 (NO)
  • 批准号:
    2305182
  • 财政年份:
    2023
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Continuing Grant
Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
  • 批准号:
    EP/X027198/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Fellowship
Stimulation of nitric oxide (NO) production in vascular endothelial cells by Raphanus sativus (Sakurajima Daikon) extracts
萝卜(樱岛萝卜)提取物刺激血管内皮细胞产生一氧化氮 (NO)
  • 批准号:
    20H02936
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Nitric Oxide (NO) inhalation to treat COVID-19: coupling in-situ NO-generating modules to ventilators
一氧化氮 (NO) 吸入治疗 COVID-19:将原位 NO 生成模块与呼吸机耦合
  • 批准号:
    71335
  • 财政年份:
    2020
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Feasibility Studies
Improvement of biocompatibility of oxygenator membrane surface by nitric oxide (NO)
一氧化氮(NO)改善氧合器膜表面的生物相容性
  • 批准号:
    19K09441
  • 财政年份:
    2019
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Verification of reduction of superoxide toxicity by nitric oxide (NO) synthase and exogenous NO
一氧化氮 (NO) 合酶和外源性 NO 降低超氧化物毒性的验证
  • 批准号:
    18K06948
  • 财政年份:
    2018
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of host tissue responses by pathogen-derived nitric oxide (NO)
病原体来源的一氧化氮 (NO) 调节宿主组织反应
  • 批准号:
    393235587
  • 财政年份:
    2017
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Research Grants
Analysis of circadian rhythm regulated by nitric oxide (NO) or Carbon monoxide (CO)
一氧化氮 (NO) 或一氧化碳 (CO) 调节的昼夜节律分析
  • 批准号:
    16K01917
  • 财政年份:
    2016
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ORGAN PROTECTION AND IMPROVEMENT OF SURVIVAL AFTER HEMORRHAGIC SHOCK BY TREATMENT WITH INHALED NITRIC OXIDE(NO) IN A RAT MODEL
吸入一氧化氮 (NO) 治疗大鼠模型的器官保护和失血性休克后存活率的提高
  • 批准号:
    15K10975
  • 财政年份:
    2015
  • 资助金额:
    $ 1.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了